In human skin, CD2+MHC-II+CCR2+ myeloid precursors were significantly more prevalent in individuals with psoriasis than in healthy control individuals (Fig. 3g and Supplementary Fig. 2b–d). This evidence concerns the gene CD2 and psoriasis.